| THE-BRIGHAM-AND-WOMEN-S-HOSPITAL-INC |
THE-BRIGHAM-AND-WOMEN-S-HOSPITAL-INC |
90%
|
we obtained an exclusive, sublicensable, worldwide license to practice under certain of BWH's patent rights for identifying T cell epitopes, which are relevant to our target discovery platform for id… |
| ALLO |
Allogene Therapeutics, Inc. |
72%
|
ding transposase enzyme, which is derived from sfR fall armyworm, to deliver our TCRs into the genome of T cells. Our transposon/transposase system effectively inserts our TCRs and other exogenous ge… |
| ALLO |
Allogene Therapeutics, Inc. |
72%
|
Reciprocal relationship from ALLO graph: Reciprocal relationship from TCRX graph: ding transposase enzyme, which is derived from sfR fall armyworm, to deliver our TCRs into the genome of T cells. Our… |
| AUTL |
Autolus Therapeutics plc |
72%
|
ding transposase enzyme, which is derived from sfR fall armyworm, to deliver our TCRs into the genome of T cells. Our transposon/transposase system effectively inserts our TCRs and other exogenous ge… |
| AUTL |
Autolus Therapeutics plc |
72%
|
Reciprocal relationship from AUTL graph: Reciprocal relationship from TCRX graph: ding transposase enzyme, which is derived from sfR fall armyworm, to deliver our TCRs into the genome of T cells. Our… |
| IOVA |
Iovance Biotherapeutics, Inc. |
72%
|
Reciprocal relationship from IOVA graph: Reciprocal relationship from TCRX graph: ding transposase enzyme, which is derived from sfR fall armyworm, to deliver our TCRs into the genome of T cells. Our… |
| IOVA |
Iovance Biotherapeutics, Inc. |
72%
|
ding transposase enzyme, which is derived from sfR fall armyworm, to deliver our TCRs into the genome of T cells. Our transposon/transposase system effectively inserts our TCRs and other exogenous ge… |
| IPSC |
Century Therapeutics, Inc. |
72%
|
Reciprocal relationship from IPSC graph: Reciprocal relationship from TCRX graph: ding transposase enzyme, which is derived from sfR fall armyworm, to deliver our TCRs into the genome of T cells. Our… |
| IPSC |
Century Therapeutics, Inc. |
72%
|
ding transposase enzyme, which is derived from sfR fall armyworm, to deliver our TCRs into the genome of T cells. Our transposon/transposase system effectively inserts our TCRs and other exogenous ge… |
| LEGN |
Legend Biotech Corporation |
72%
|
ding transposase enzyme, which is derived from sfR fall armyworm, to deliver our TCRs into the genome of T cells. Our transposon/transposase system effectively inserts our TCRs and other exogenous ge… |
| LEGN |
Legend Biotech Corporation |
72%
|
Reciprocal relationship from LEGN graph: Reciprocal relationship from TCRX graph: Reciprocal relationship from LEGN graph: Reciprocal relationship from TCRX graph: ding transposase enzyme, which is d… |
| LYEL |
Lyell Immunopharma, Inc. |
72%
|
Reciprocal relationship from LYEL graph: Reciprocal relationship from TCRX graph: Reciprocal relationship from LYEL graph: Reciprocal relationship from TCRX graph: ding transposase enzyme, which is d… |
| LYEL |
Lyell Immunopharma, Inc. |
72%
|
ding transposase enzyme, which is derived from sfR fall armyworm, to deliver our TCRs into the genome of T cells. Our transposon/transposase system effectively inserts our TCRs and other exogenous ge… |
| MRKR |
Marker Therapeutics, Inc. |
72%
|
Reciprocal relationship from MRKR graph: Reciprocal relationship from TCRX graph: Reciprocal relationship from MRKR graph: Reciprocal relationship from TCRX graph: ding transposase enzyme, which is d… |
| MRKR |
Marker Therapeutics, Inc. |
72%
|
ding transposase enzyme, which is derived from sfR fall armyworm, to deliver our TCRs into the genome of T cells. Our transposon/transposase system effectively inserts our TCRs and other exogenous ge… |
| NVSEF |
Novartis AG |
72%
|
Reciprocal relationship from NVSEF graph: Reciprocal relationship from TCRX graph: ake estimates and judgments that affect the reported amounts of assets, liabilities, costs and expenses. We base our… |
| NVSEF |
Novartis AG |
72%
|
ake estimates and judgments that affect the reported amounts of assets, liabilities, costs and expenses. We base our estimates on historical experience, known trends and events and various other fact… |
| REGN |
Regeneron Pharmaceuticals, Inc. |
72%
|
Reciprocal relationship from REGN graph: Reciprocal relationship from TCRX graph: Reciprocal relationship from REGN graph: Reciprocal relationship from TCRX graph: Reciprocal relationship from REGN g… |
| REGN |
Regeneron Pharmaceuticals, Inc. |
72%
|
ding transposase enzyme, which is derived from sfR fall armyworm, to deliver our TCRs into the genome of T cells. Our transposon/transposase system effectively inserts our TCRs and other exogenous ge… |
